Fig. 4.
Model of the RANK/RANKL/osteoprotegerin pathway for osteoclastic alveolar bone loss in periodontal disease. Also shown are potential sites for blocking these deleterious reactions with various ‘biologicals’ based upon receptor–ligand engagement and intracellular signaling pathways. OPG, osteoprotegerin.